Literature DB >> 7616244

Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults.

D Y Ho1, T C Saydam, S L Fink, M S Lawrence, R M Sapolsky.   

Abstract

Because neurons are postmitotic, they are irreplaceable once they succumb to necrotic insults such as hypoglycemia, ischemia, and seizure. A paucity of energy can exacerbate the toxicities of these insults; thus, a plausible route to protect neurons from necrotic injury would be to enhance their glucose uptake capability. We have demonstrated previously that defective herpes simplex virus (HSV) vectors overexpressing the rat brain glucose transporter (GT) gene (gt) can enhance glucose uptake in adult rat hippocampus and in hippocampal cultures. Furthermore, we have observed that such vectors can maintain neuronal metabolism during hypoglycemia and reduce kainic acid-induced seizure damage. In this study, we have developed bicistronic vectors that coexpressed gt and Escherichia coli lacZ as a reporter gene, which allows us to identify directly neurons that are infected with the vectors. Overexpression of GT from these vectors protected cultured hippocampal, spinal cord, and septal neurons against various necrotic insults, including hypoglycemia, glutamate, and 3-nitropropionic acid. Our observations demonstrate the feasibility of using HSV vectors to protect neurons from necrotic insults. Although this study has concentrated on the delivery of gt, other genes with therapeutic or protective capability might also be used.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616244     DOI: 10.1046/j.1471-4159.1995.65020842.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Sparing of neuronal function postseizure with gene therapy.

Authors:  J McLaughlin; B Roozendaal; T Dumas; A Gupta; O Ajilore; J Hsieh; D Ho; M Lawrence; J L McGaugh; R Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 2.  Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity.

Authors:  B S McEwen
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 3.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

4.  Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics.

Authors:  Tonya M Bliss; Miranda Ip; Elise Cheng; Masabumi Minami; Luc Pellerin; Pierre Magistretti; Robert M Sapolsky
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

5.  An enhanced packaging system for helper-dependent herpes simplex virus vectors.

Authors:  T A Stavropoulos; C A Strathdee
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 6.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

7.  Neuroprotective potential of a viral vector system induced by a neurological insult.

Authors:  C R Ozawa; J J Ho; D J Tsai; D Y Ho; R M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

8.  Cortical 5HT 2A receptor function under hypoxia in neonatal rats: role of glucose, oxygen, and epinephrine resuscitation.

Authors:  T R Anju; S Smijin; P K Korah; C S Paulose
Journal:  J Mol Neurosci       Date:  2010-09-21       Impact factor: 3.444

9.  Neuroprotective effect of high glucose against NMDA, free radical, and oxygen-glucose deprivation through enhanced mitochondrial potentials.

Authors:  S Y Seo; E Y Kim; H Kim; B J Gwag
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

10.  Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression.

Authors:  C S Paulose; Finla Chathu; S Reas Khan; Amee Krishnakumar
Journal:  Neurochem Res       Date:  2007-10-18       Impact factor: 3.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.